⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
PFE News
Pfizer Inc.
Companion Diagnostics Market Research 2025: $21+ Bn Opportunities, Growth Drivers, Industry Trend Analysis, and Forecasts 2024-2034
globenewswire.com
PFE
MRK
AZN
TMO
ABT
AMGN
JNJ
BMY
LLY
MYGN
GRDX
BIIB
BDX
OTR Therapeutics Raises $100 Million in Series A Financing to Advance Early Innovation into Global Transformative Therapies
prnewswire.com
PFE
Acute Myeloid Leukemia Clinical Trial Pipeline Appears Robust With 100+ Key Pharma Companies Actively Working in the Domain | DelveInsight
globenewswire.com
JAZZ
PRE
ABBV
AMGN
GILD
BMY
AZN
INCY
PFE
CELC
G2 Names DataCamp as a Leader in Technical Skills Development and Enterprise Online Learning
businesswire.com
GOOG
UBER
NKE
PFE
Pharmaceutical Marketing Industry Trends and Emerging Opportunities 2025-2032 Featuring Syneos Health, McCann Health, Amgen, AXPIRA, Pfizer and More - ResearchAndMarkets.com
businesswire.com
SNY
AMGN
PFE
Bio/Pharmaceutical Outsourcing Report, October 2025 - Pfizer and Roche Place $10 Billion Bets on Obesity and Liver Disease Therapies as Trump Tightens Grip on Drug Pricing and Manufacturing
globenewswire.com
PFE
Renowned Immunologist and Urological Surgeon Dr. Marvin Hausman Featured in New Exousia Bio, Inc. Interview
globenewswire.com
PFE
Beghou Adds New Partners to Advance Integrated, Experience-Driven Commercialization in Life Sciences
globenewswire.com
PFE
Alors que le nombre de décès d'enfants devrait augmenter pour la première fois au cours de ce siècle, la Fondation Gates exhorte les dirigeants mondiaux à cibler les ressources limitées là où elles permettent de sauver le plus de vies. USA - Français USA
prnewswire.com
BMY
JNJ
PFE
MRK
GILD
Hemophilia A Market to Exhibit Growth at a CAGR of 2.9% During the Forecast Period (2025-2034) Owing to the Rising Hemophilia Prevalence, Strong Uptake of New Drugs, and Emergence of High-cost Gene Therapies | DelveInsight
prnewswire.com
NVO
ULTX
SGMO
PFE
BMN
SNY
CHGC
RHHBY
ALNY
BIIB
BAY
TSEM
CSL
HEMA
LFB
OCT
SOBI
ASC